Cargando…

Takaysu arteritis treatment in children

Detalles Bibliográficos
Autores principales:	Kostina, YO, Lyskina, GA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191709/ http://dx.doi.org/10.1186/1546-0096-12-S1-P355

Ejemplares similares

Anti-tumor necrosis factor therapy in children with refractory Takayasu arteritis: report of five cases
por: Kostina, YO, et al.
Publicado: (2011)

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma
por: Osminina, MK, et al.
Publicado: (2008)

Takayasu's arteritis in childhood
por: Brunner, J
Publicado: (2008)

Bentall procedure in Takayasu arteritis
por: Hidiroglu, M, et al.
Publicado: (2013)

49. Giant cell arteritis and Takayasu arteritis: two sides of the same coin in an elderly female?
por: Ghuman, Hira, et al.
Publicado: (2019)

Horner syndrome as a manifestation of an exacerbation of Takayasu’s arteritis
por: Co, Dominic, et al.
Publicado: (2012)

Brazilian multicentre study of Takayasu’s arteritis in children and adolescents – preliminary results of a clinical, imaging and therapeutic study
por: Terreri, Maria Teresa, et al.
Publicado: (2011)

39. Atypical presentation of giant cell arteritis confirmed on brain biopsy
por: Ahmad, Nadia, et al.
Publicado: (2019)

38. Bilateral internuclear ophthalmoplegia and third nerve palsy in giant cell arteritis
por: El-Ghazali, Shawki, et al.
Publicado: (2019)

48. Dry cough and pleural effusion as presenting features of giant cell arteritis
por: Sharma, Seema, et al.
Publicado: (2019)

PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy
por: Yamazaki, K, et al.
Publicado: (2013)

33. A case of ocular ischaemic syndrome caused by severe giant cell arteritis
por: Onac, Ioana, et al.
Publicado: (2019)

55. A case for continuing tocilizumab beyond 12 months in giant cell arteritis?
por: Ming, Caroline, et al.
Publicado: (2019)

Association of FCGR2A and Fc gamma receptor haplotypes with Spanish polymyalgia rheumatica and giant cell arteritis
por: Morgan, AW, et al.
Publicado: (2005)

31. Takayasu arteritis presenting as bilateral popliteal artery aneurysm: a rare presentation of a rare disease
por: Abdulkarim, Saadeya, et al.
Publicado: (2019)

52. Not every rheumatologic headache is giant cell arteritis: a case of aseptic meningitis on a background of rheumatoid arthritis
por: Magan, Priyan, et al.
Publicado: (2019)

Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis
por: Rokhlina, FV, et al.
Publicado: (2011)

Delayed contrast-enhanced MRI of the coronary artery wall in patients with Takayasu's arteritis: initial experience and comparison to patients with stable coronary artery disease
por: Schneeweis, Christopher, et al.
Publicado: (2012)

Dilatation of the thoracic aorta and increased arterial stiffness is common in patients with giant cell arteritis - preliminary findings from a cardiac magnetic resonance study
por: Erhayiem, Bara, et al.
Publicado: (2015)

Amphotericin B® treatment causes QT prolongation in lung transplant-patients
por: Tudor, B-A, et al.
Publicado: (2015)

Multidisciplinary treatment in children with ectodermal dysplasia
por: Norderyd, J
Publicado: (2012)

Behcet Disease: treatment of vascular involvement in children
por: Bilginer, Y, et al.
Publicado: (2008)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
por: Marco, A, et al.
Publicado: (2008)

Intermittent preventive treatment for children (IPTC) combined with timely home treatment for malaria control
por: Ahorlu, Collins K, et al.
Publicado: (2012)

Takayasu arteritis in children
por: Al abrawi, Safia, et al.
Publicado: (2008)

17. Angiolymphoid hyperplasia with eosinophilia mimicking temporal arteritis
por: Ansari, Ghazal, et al.
Publicado: (2019)

The response to hepatitis a vaccine in children with JIA on immunosuppresive treatment
por: Maritsi, Despoina, et al.
Publicado: (2014)

Bisphosphonates as treatment of secondary osteoporosis in children: a case series
por: Soesanti, Frida, et al.
Publicado: (2015)

P-075: HYDROXYUREA: EFFECTS ON TREATMENT OF CHILDREN WITH HEMOGLOBINOPATHY SC
por: A., CAMPOS, et al.
Publicado: (2022)

Cardiovascular outcomes following Kawasaki disease in Moscow, Russia: A single center experience
por: Lyskina, Galina, et al.
Publicado: (2017)

Comparative evaluation of ARV therapy efficiency among patients at the Kiev regional AIDS center
por: Yurchenko, YO, et al.
Publicado: (2010)

The role of the TRAF2/3 binding site in LMP1 and CD40 signaling
por: Graham, JP, et al.
Publicado: (2009)

P10 - Antileukotriene treatment in children with bronchial asthma and allergic rhinitis
por: Karimova, Maleyka
Publicado: (2014)

Severe food allergy in children. Omalizumab as an alternative treatment to elimination diet
por: Pena Peloche, María, et al.
Publicado: (2011)

TGF-beta signalling contributes to thymic epithelial cell damage and regeneration following myeloablative conditioning and stem-cell transplantation
por: Hauri-Hohl, MM, et al.
Publicado: (2008)

Effects of antirheumatic treatment with tocilizumab on longitudinal growth in children with juvenile idiopathic arthritis
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Antibiotic treatment of Clostridium difficile infection in children – a challenge in pediatric practice
por: Leşanu, Gabriela, et al.
Publicado: (2014)

Erdheim-Chester disease in children: clinical, radiologic, treatment characteristics of three cases
por: Eyssette-Guerreau, S, et al.
Publicado: (2008)

Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment
por: Konopelko, OU, et al.
Publicado: (2011)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
por: Alexeeva, E, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p2h5uskks2k860lb3q180s2hi5